




Searching News Database: bipolar
HSMN NewsFeed - 30 Aug 2023
Alkermes Announces Settlement With Teva Related to VIVITROL(R) Patent Litigation
Alkermes Announces Settlement With Teva Related to VIVITROL(R) Patent Litigation
HSMN NewsFeed - 17 Oct 2022
Medtronic First to Receive FDA Approval for Pacing the Heart's Natural Conduction System
Medtronic First to Receive FDA Approval for Pacing the Heart's Natural Conduction System
HSMN NewsFeed - 28 Mar 2022
Jazz Pharmaceuticals Announces Agreement to Divest Sunosi(R) (solriamfetol) to Axsome Therapeutics
Jazz Pharmaceuticals Announces Agreement to Divest Sunosi(R) (solriamfetol) to Axsome Therapeutics
HSMN NewsFeed - 18 Mar 2022
NRx Pharmaceuticals, Inc. Appoints Ira Strassberg as Chief Financial Officer and Treasurer
NRx Pharmaceuticals, Inc. Appoints Ira Strassberg as Chief Financial Officer and Treasurer
HSMN NewsFeed - 23 Dec 2021
Healis Therapeutics announces mission to deliver new class of neuromuscular treatments in psychiatry
Healis Therapeutics announces mission to deliver new class of neuromuscular treatments in psychiatry
HSMN NewsFeed - 2 Aug 2021
Alkermes Receives FDA Fast Track Designation for Nemvaleukin Alfa for the Treatment of Mucosal Melanoma
Alkermes Receives FDA Fast Track Designation for Nemvaleukin Alfa for the Treatment of Mucosal Melanoma
HSMN NewsFeed - 21 Jun 2021
Ethicon Expands Advanced Biopolar Energy Portfolio With Launch Of ENSEAL X1 Curved Jaw Tissue Sealer
Ethicon Expands Advanced Biopolar Energy Portfolio With Launch Of ENSEAL X1 Curved Jaw Tissue Sealer
HSMN NewsFeed - 11 Mar 2021
Alkermes Announces FDA Orphan Drug Designation for Nemvaleukin Alfa for Treatment of Mucosal Melanoma
Alkermes Announces FDA Orphan Drug Designation for Nemvaleukin Alfa for Treatment of Mucosal Melanoma
HSMN NewsFeed - 23 Oct 2019
NeuroRx Secures HK$ 750 Million Capital Commitment From The Gem Group for Development of NRX-101
NeuroRx Secures HK$ 750 Million Capital Commitment From The Gem Group for Development of NRX-101
HSMN NewsFeed - 15 Jul 2019
Alkermes Expands Planned New Drug Application for ALKS 3831 to Include Treatment of Bipolar I Disorder
Alkermes Expands Planned New Drug Application for ALKS 3831 to Include Treatment of Bipolar I Disorder
HSMN NewsFeed - 30 May 2018
Olympus Launches the DualKnife J, an ESD Electrosurgical Knife That Shortens Procedure Time
Olympus Launches the DualKnife J, an ESD Electrosurgical Knife That Shortens Procedure Time
HSMN NewsFeed - 28 May 2018
Luye Pharma Acquires AstraZeneca's Signature Products Seroquel and Seroquel XR
Luye Pharma Acquires AstraZeneca's Signature Products Seroquel and Seroquel XR
HSMN NewsFeed - 8 Jun 2016
Orexigen Therapeutics Reports Favorable Markman Ruling in Contrave(R) Patent Litigation
Orexigen Therapeutics Reports Favorable Markman Ruling in Contrave(R) Patent Litigation
HSMN NewsFeed - 17 Nov 2014
First U.S. Procedures Completed With The Symphion(TM) Hysteroscopic Tissue Removal System
First U.S. Procedures Completed With The Symphion(TM) Hysteroscopic Tissue Removal System
HSMN NewsFeed - 9 Apr 2014
Brainsway's Deep TMS System Will be Exclusively Marketed by Medison Pharma in Israel
Brainsway's Deep TMS System Will be Exclusively Marketed by Medison Pharma in Israel
HSMN NewsFeed - 18 Feb 2014
Actavis to Acquire Forest Laboratories, Inc. for ~$25 Billion in an Equity and Cash Transaction
Actavis to Acquire Forest Laboratories, Inc. for ~$25 Billion in an Equity and Cash Transaction
HSMN NewsFeed - 22 Jan 2014
Covidien Receives U.S. Food and Drug Administration Clearance for LigaSure(TM) Maryland Jaw
Covidien Receives U.S. Food and Drug Administration Clearance for LigaSure(TM) Maryland Jaw
HSMN NewsFeed - 11 Dec 2013
Ethicon Receives 510(k) Clearance for New HARMONIC FOCUS(R)+ Shears with Adaptive Tissue Technology
Ethicon Receives 510(k) Clearance for New HARMONIC FOCUS(R)+ Shears with Adaptive Tissue Technology
HSMN NewsFeed - 2 Dec 2013
Forest to Acquire U.S. Marketing Rights to Saphris(R) (asenapine) from Merck
Forest to Acquire U.S. Marketing Rights to Saphris(R) (asenapine) from Merck
HSMN NewsFeed - 21 Nov 2013
Forest Laboratories and Gedeon Richter Receive Complete Response Letter for Cariprazine
Forest Laboratories and Gedeon Richter Receive Complete Response Letter for Cariprazine
HSMN NewsFeed - 11 Nov 2013
Ethicon Energy Launches ENSEAL(R) G2 Articulating at AAGL Global Congress on Minimally Invasive Gynecology
Ethicon Energy Launches ENSEAL(R) G2 Articulating at AAGL Global Congress on Minimally Invasive Gynecology
HSMN NewsFeed - 29 Oct 2013
Ethicon Receives 510(k) Clearance of Ear, Nose and Throat (ENT) Indication for ENSEAL(R) Tissue Sealers
Ethicon Receives 510(k) Clearance of Ear, Nose and Throat (ENT) Indication for ENSEAL(R) Tissue Sealers
HSMN NewsFeed - 28 Oct 2013
Ethicon Receives 510(k) Clearance for New HARMONIC ACE(R)+ 7 Shears with Advanced Hemostasis
Ethicon Receives 510(k) Clearance for New HARMONIC ACE(R)+ 7 Shears with Advanced Hemostasis
HSMN NewsFeed - 30 Jul 2013
Alexza Pharmaceuticals Announces European Launch of ADASUVE(R) (Staccato(R) Loxapine)
Alexza Pharmaceuticals Announces European Launch of ADASUVE(R) (Staccato(R) Loxapine)
HSMN NewsFeed - 17 May 2013
Boston Scientific Schedule of Major Events and Presentations at EuroPCR 2013
Boston Scientific Schedule of Major Events and Presentations at EuroPCR 2013
HSMN NewsFeed - 8 May 2013
Teva and Alexza Announce Teva’s License to Market ADASUVE(R) in the U.S.
Teva and Alexza Announce Teva’s License to Market ADASUVE(R) in the U.S.
HSMN NewsFeed - 30 Apr 2013
St. Jude Medical Announces CE Mark and Launch of First Quadripolar CRT Pacemaker
St. Jude Medical Announces CE Mark and Launch of First Quadripolar CRT Pacemaker
HSMN NewsFeed - 21 Feb 2013
Alexza Receives Marketing Authorization for ADASUVE(R) (Staccato(R) Loxapine) in the European Union
Alexza Receives Marketing Authorization for ADASUVE(R) (Staccato(R) Loxapine) in the European Union
HSMN NewsFeed - 4 Feb 2013
Ethicon Receives 510(k) Clearance for ENSEAL(R) G2 Articulating Tissue Sealer
Ethicon Receives 510(k) Clearance for ENSEAL(R) G2 Articulating Tissue Sealer
HSMN NewsFeed - 17 Oct 2012
DelRey ENT Associates Enhances the Care and Comfort of Tonsillectomy Patients with Thermal Fusion Technology
DelRey ENT Associates Enhances the Care and Comfort of Tonsillectomy Patients with Thermal Fusion Technology
HSMN NewsFeed - 22 Aug 2012
Wockhardt receives tentative US FDA approval for generic version of anti-psychotic drug Geodon(R)
Wockhardt receives tentative US FDA approval for generic version of anti-psychotic drug Geodon(R)
HSMN NewsFeed - 16 Aug 2012
First Cardiac Surgery with Domain Surgical FMwand Completed at Beaumont Hospital
First Cardiac Surgery with Domain Surgical FMwand Completed at Beaumont Hospital
HSMN NewsFeed - 10 Aug 2012
Neuren Appoints Joseph Horrigan, M.D., as VP of Clinical Development and Medical Affairs
Neuren Appoints Joseph Horrigan, M.D., as VP of Clinical Development and Medical Affairs
HSMN NewsFeed - 12 Jul 2012
Covidien Announces New Bipolar Resection Software Application for ForceTriad(TM) Energy Platform
Covidien Announces New Bipolar Resection Software Application for ForceTriad(TM) Energy Platform
HSMN NewsFeed - 1 May 2012
Vessix Receives CE Mark For V2 Renal Denervation System(TM) For Treatment Of Hypertension
Vessix Receives CE Mark For V2 Renal Denervation System(TM) For Treatment Of Hypertension
HSMN NewsFeed - 8 Mar 2012
The Radiosurgery Society(TM) Completes its First Scientific Meeting as an Independent Society
The Radiosurgery Society(TM) Completes its First Scientific Meeting as an Independent Society
HSMN NewsFeed - 23 Jan 2012
Medtronic Announces 510(k) Clearance for the Aquamantys SBS 5.0 Sheathed Bipolar Sealer for Spine Surgery
Medtronic Announces 510(k) Clearance for the Aquamantys SBS 5.0 Sheathed Bipolar Sealer for Spine Surgery
HSMN NewsFeed - 2 Dec 2011
Missouri Baptist Medical Center Physicians Are First in Missouri to Implant New Heart Failure Device
Missouri Baptist Medical Center Physicians Are First in Missouri to Implant New Heart Failure Device
HSMN NewsFeed - 12 Oct 2011
Neuralstem Receives Notice of Patent Allowance for Spinal Cord Delivery Platform
Neuralstem Receives Notice of Patent Allowance for Spinal Cord Delivery Platform
HSMN NewsFeed - 5 May 2011
Boston Scientific Offers New CRT-D Warranty Program Covering Phrenic Nerve Stimulation
Boston Scientific Offers New CRT-D Warranty Program Covering Phrenic Nerve Stimulation
HSMN NewsFeed - 2 May 2011
Sorin Group Launches the VascuClear(TM) Endoscopic Vessel Harvesting System
Sorin Group Launches the VascuClear(TM) Endoscopic Vessel Harvesting System
HSMN NewsFeed - 31 Mar 2011
Microline Surgical Launches MiSeal(TM) Reposable Thermal Ligating System at SAGES 2011 Annual Meeting
Microline Surgical Launches MiSeal(TM) Reposable Thermal Ligating System at SAGES 2011 Annual Meeting
HSMN NewsFeed - 9 Mar 2011
Salient Surgical Technologies Settles Bovie Medical Patent Infringement Lawsuit
Salient Surgical Technologies Settles Bovie Medical Patent Infringement Lawsuit
HSMN NewsFeed - 4 Mar 2011
Bovie Medical Corporation Announces Settlement of Litigation with Salient Surgical and Medtronic
Bovie Medical Corporation Announces Settlement of Litigation with Salient Surgical and Medtronic
HSMN NewsFeed - 24 Jan 2011
Bausch & Lomb Storz(R) Ophthalmics Introduces Additions to Its Single-Use Vitreoretinal Instruments Line
Bausch & Lomb Storz(R) Ophthalmics Introduces Additions to Its Single-Use Vitreoretinal Instruments Line
HSMN NewsFeed - 24 Jan 2011
Clinical Data, Inc. Announces FDA Approval of Viibryd(TM) (vilazodone HCl) for Major Depressive Disorder
Clinical Data, Inc. Announces FDA Approval of Viibryd(TM) (vilazodone HCl) for Major Depressive Disorder
HSMN NewsFeed - 4 Oct 2010
Estech Launches the COBRA Revolution(TM) Bipolar Clamp for Surgical Ablation
Estech Launches the COBRA Revolution(TM) Bipolar Clamp for Surgical Ablation
HSMN NewsFeed - 10 Aug 2010
Labopharm announces U.S. launch of OLEPTRO(TM) for treatment of major depressive disorder in adults
Labopharm announces U.S. launch of OLEPTRO(TM) for treatment of major depressive disorder in adults
HSMN NewsFeed - 22 Jul 2010
Alexza Pharmaceuticals Appoints Joseph L. Turner to Its Board of Directors
Alexza Pharmaceuticals Appoints Joseph L. Turner to Its Board of Directors
HSMN NewsFeed - 14 May 2010
Epizyme Appoints Mikel Moyer, Ph.D., Vice President of Molecular Discovery
Epizyme Appoints Mikel Moyer, Ph.D., Vice President of Molecular Discovery
HSMN NewsFeed - 14 Apr 2010
Salient Surgical Brings the Benefits of TRANSCOLLATION(TM) Technology to the Orthopedic Trauma Market
Salient Surgical Brings the Benefits of TRANSCOLLATION(TM) Technology to the Orthopedic Trauma Market
HSMN NewsFeed - 19 Mar 2010
Bovie Medical Corporation Announces Clearance to Market Its BOSS Soft Tissue Coagulation Device
Bovie Medical Corporation Announces Clearance to Market Its BOSS Soft Tissue Coagulation Device
HSMN NewsFeed - 12 Mar 2010
Bovie Medical Corporation Announces Clearance to Market Its ICON VS Electrosurgical Generator
Bovie Medical Corporation Announces Clearance to Market Its ICON VS Electrosurgical Generator
HSMN NewsFeed - 11 Mar 2010
Illumina and Glenn Close Announce the First Full Coverage DNA Sequencing of a Named Female
Illumina and Glenn Close Announce the First Full Coverage DNA Sequencing of a Named Female
HSMN NewsFeed - 14 Dec 2009
FDA Approves Lilly's ZYPREXA(R) RELPREVV(TM) for Treatment of Schizophrenia in Adults
FDA Approves Lilly's ZYPREXA(R) RELPREVV(TM) for Treatment of Schizophrenia in Adults
HSMN NewsFeed - 4 Dec 2009
US FDA Approves SEROQUEL XR(R) For Add-On Treatment of Major Depressive Disorder
US FDA Approves SEROQUEL XR(R) For Add-On Treatment of Major Depressive Disorder
HSMN NewsFeed - 30 Nov 2009
FDA Approves Cymbalta(R) for Maintenance Treatment of Generalized Anxiety Disorder
FDA Approves Cymbalta(R) for Maintenance Treatment of Generalized Anxiety Disorder
HSMN NewsFeed - 16 Sep 2009
Medtronic Launches New and Innovative Intraoperative Nerve Integrity Monitors for Surgeons
Medtronic Launches New and Innovative Intraoperative Nerve Integrity Monitors for Surgeons
HSMN NewsFeed - 14 Sep 2009
Schering-Plough Reports Data From SAPHRIS(R) (asenapine) Long-Term Schizophrenia Relapse Prevention Study
Schering-Plough Reports Data From SAPHRIS(R) (asenapine) Long-Term Schizophrenia Relapse Prevention Study
HSMN NewsFeed - 11 Sep 2009
New Data Show Patients With Chronic Low Back Pain Maintained Pain Reduction on Cymbalta(R)
New Data Show Patients With Chronic Low Back Pain Maintained Pain Reduction on Cymbalta(R)
HSMN NewsFeed - 19 Jun 2009
Covidien Features New Devices for Minimally Invasive Surgery and Soft Tissue Repair at ASMBS 2009
Covidien Features New Devices for Minimally Invasive Surgery and Soft Tissue Repair at ASMBS 2009
HSMN NewsFeed - 11 May 2009
Eurand Announces FDA Approval of EUR-1048 (Lamictal(R) ODT(TM)), Co-Developed With GlaxoSmithKline
Eurand Announces FDA Approval of EUR-1048 (Lamictal(R) ODT(TM)), Co-Developed With GlaxoSmithKline
HSMN NewsFeed - 23 Mar 2009
FDA Approves Symbyax(R) as First Medication for Treatment-Resistant Depression
FDA Approves Symbyax(R) as First Medication for Treatment-Resistant Depression
HSMN NewsFeed - 17 Mar 2009
Cephalon Announces Positive Results From a Phase Two Study of NUVIGIL in Bipolar Depression
Cephalon Announces Positive Results From a Phase Two Study of NUVIGIL in Bipolar Depression
HSMN NewsFeed - 16 Mar 2009
Shire Withdraws European Application for DAYTRANA(TM) (Methylphenidate Transdermal System)
Shire Withdraws European Application for DAYTRANA(TM) (Methylphenidate Transdermal System)
HSMN NewsFeed - 24 Feb 2009
Hydromer, Inc. Announces Sale of Product Lines to Merit Medical Systems, Inc.
Hydromer, Inc. Announces Sale of Product Lines to Merit Medical Systems, Inc.
HSMN NewsFeed - 23 Feb 2009
AstraZeneca Announces SEROQUEL XR is Now Available to Treat Bipolar Depression
AstraZeneca Announces SEROQUEL XR is Now Available to Treat Bipolar Depression
HSMN NewsFeed - 29 Jan 2009
Alexza Consolidates Operations to Focus Resources on AZ-004 (Staccato(R) Loxapine) for Acute Agitation
Alexza Consolidates Operations to Focus Resources on AZ-004 (Staccato(R) Loxapine) for Acute Agitation
HSMN NewsFeed - 28 Jan 2009
Mylan Receives Final FDA Approvals for Generic Versions of Lamictal(R) Tablets and Lamictal(R) CD
Mylan Receives Final FDA Approvals for Generic Versions of Lamictal(R) Tablets and Lamictal(R) CD
HSMN NewsFeed - 22 Jan 2009
Cardo Medical Announces the Initial Release of Its Press-Fit Total Hip System
Cardo Medical Announces the Initial Release of Its Press-Fit Total Hip System
HSMN NewsFeed - 15 Jan 2009
Lilly Resolves Investigations of Past Zyprexa Marketing and Promotional Practices
Lilly Resolves Investigations of Past Zyprexa Marketing and Promotional Practices
HSMN NewsFeed - 10 Oct 2008
FDA Approves AstraZeneca's SEROQUEL XR(R) for the Treatment of Bipolar Depression and Bipolar Mania
FDA Approves AstraZeneca's SEROQUEL XR(R) for the Treatment of Bipolar Depression and Bipolar Mania
HSMN NewsFeed - 16 Sep 2008
Mylan Receives FDA Approval for Generic Version of Anti-Psychotic Risperdal(R)
Mylan Receives FDA Approval for Generic Version of Anti-Psychotic Risperdal(R)
HSMN NewsFeed - 5 Aug 2008
Marinus Pharmaceuticals Appoints John Krayacich as President and Chief Executive Officer
Marinus Pharmaceuticals Appoints John Krayacich as President and Chief Executive Officer
HSMN NewsFeed - 31 Jul 2008
Sierra Neuropharmaceuticals Completes $21.5-Million Series A Funding Round
Sierra Neuropharmaceuticals Completes $21.5-Million Series A Funding Round
HSMN NewsFeed - 30 Jul 2008
Banner Pharmacaps Receives FDA Approval for Valproic Acid Delayed Release Softgel Capsules
Banner Pharmacaps Receives FDA Approval for Valproic Acid Delayed Release Softgel Capsules
HSMN NewsFeed - 11 Jun 2008
CeNeRx BioPharma Appoints Mahnaz Asgharnejad as Vice President of Clinical Development
CeNeRx BioPharma Appoints Mahnaz Asgharnejad as Vice President of Clinical Development
HSMN NewsFeed - 29 May 2008
Anthony Clarke, PhD Joins Alexza Pharmaceuticals as Vice President, International Development Operations
Anthony Clarke, PhD Joins Alexza Pharmaceuticals as Vice President, International Development Operations
HSMN NewsFeed - 19 May 2008
Jeffrey S. Williams Rejoins Alexza Pharmaceuticals as President, Alexza Singapore Pte. Ltd.
Jeffrey S. Williams Rejoins Alexza Pharmaceuticals as President, Alexza Singapore Pte. Ltd.
HSMN NewsFeed - 15 May 2008
Wyeth's Pristiq, a New Treatment for Major Depressive Disorder in Adults, Now Available in U.S. Pharmacies
Wyeth's Pristiq, a New Treatment for Major Depressive Disorder in Adults, Now Available in U.S. Pharmacies
HSMN NewsFeed - 14 May 2008
FDA Approves AstraZeneca's Seroquel(R) for Maintenance Treatment in Bipolar Disorder
FDA Approves AstraZeneca's Seroquel(R) for Maintenance Treatment in Bipolar Disorder
HSMN NewsFeed - 8 May 2008
FDA Approves Strattera(R) for Maintenance of ADHD in Children and Adolescents
FDA Approves Strattera(R) for Maintenance of ADHD in Children and Adolescents
HSMN NewsFeed - 18 Mar 2008
AtriCure's Coolrail(TM) Linear Ablation Pen Receives FDA 510(k) Clearance
AtriCure's Coolrail(TM) Linear Ablation Pen Receives FDA 510(k) Clearance
HSMN NewsFeed - 12 Mar 2008
Statement from Eli Lilly and Company: Response to Connecticut Attorney General News Release
Statement from Eli Lilly and Company: Response to Connecticut Attorney General News Release
HSMN NewsFeed - 29 Feb 2008
AstraZeneca Submits sNDA for SEROQUEL XR(TM) for the Treatment of Major Depressive Disorder
AstraZeneca Submits sNDA for SEROQUEL XR(TM) for the Treatment of Major Depressive Disorder
HSMN NewsFeed - 27 Feb 2008
Michael J. Simms Joins Alexza Pharmaceuticals as Senior Vice President, Operations and Manufacturing
Michael J. Simms Joins Alexza Pharmaceuticals as Senior Vice President, Operations and Manufacturing
HSMN NewsFeed - 25 Feb 2008
Alexza Initiates First Phase 3 Clinical Trial for AZ-004 (Staccato(R) Loxapine)
Alexza Initiates First Phase 3 Clinical Trial for AZ-004 (Staccato(R) Loxapine)
HSMN NewsFeed - 31 Jan 2008
Starion Achieves Worldwide Distribution of Proprietary Tissue Welding Technology
Starion Achieves Worldwide Distribution of Proprietary Tissue Welding Technology
HSMN NewsFeed - 18 Jan 2008
Pfizer Statement on CHANTIX (varenicline) Labeling Update in the United States
Pfizer Statement on CHANTIX (varenicline) Labeling Update in the United States
HSMN NewsFeed - 14 Jan 2008
Surgeons and Electrophysiologist Publish Positive Data Using AtriCure Minimally Invasive Products
Surgeons and Electrophysiologist Publish Positive Data Using AtriCure Minimally Invasive Products
HSMN NewsFeed - 26 Dec 2007
Noven Announces FDA Tentative Approval of Stavzor(TM) Valproic Acid Delayed Release Capsules
Noven Announces FDA Tentative Approval of Stavzor(TM) Valproic Acid Delayed Release Capsules
HSMN NewsFeed - 12 Dec 2007
INVEGA(TM) Shows Favorable Long-Term Safety Profile in a One-Year Study of Patients With Schizophrenia
INVEGA(TM) Shows Favorable Long-Term Safety Profile in a One-Year Study of Patients With Schizophrenia
HSMN NewsFeed - 26 Nov 2007
Synergetics USA, Inc. Adds New Electrosurgical Generator to Its Neurosurgical Product Line
Synergetics USA, Inc. Adds New Electrosurgical Generator to Its Neurosurgical Product Line
HSMN NewsFeed - 16 Nov 2007
SEROQUEL XR(TM) Receives Approval From FDA for Maintenance Treatment of Schizophrenia
SEROQUEL XR(TM) Receives Approval From FDA for Maintenance Treatment of Schizophrenia
HSMN NewsFeed - 12 Nov 2007
Caraco Pharmaceutical Laboratories, Ltd. Announces Tentative FDA Approval for Generic Lamictal(R)
Caraco Pharmaceutical Laboratories, Ltd. Announces Tentative FDA Approval for Generic Lamictal(R)
HSMN NewsFeed - 9 Nov 2007
Synergetics Announces a New Executive Vice President of Sales and Marketing
Synergetics Announces a New Executive Vice President of Sales and Marketing
HSMN NewsFeed - 30 Oct 2007
Synergetics USA, Inc. Adds "Energy BurstTM" to Malis(R) AdvantageTM Electrosurgical Generator
Synergetics USA, Inc. Adds "Energy BurstTM" to Malis(R) AdvantageTM Electrosurgical Generator
HSMN NewsFeed - 23 Oct 2007
FDA Issues Approvable Letter for Stavzor(TM) Delayed Release Valproic Acid Capsules
FDA Issues Approvable Letter for Stavzor(TM) Delayed Release Valproic Acid Capsules
HSMN NewsFeed - 8 Oct 2007
Immersion Medical Introduces OB/GYN Module for LaparoscopyVR(TM) Surgical Simulator
Immersion Medical Introduces OB/GYN Module for LaparoscopyVR(TM) Surgical Simulator
HSMN NewsFeed - 20 Sep 2007
Robert S. Fishman, MD, FCCP Joins Alexza as Vice President, Medical Affairs
Robert S. Fishman, MD, FCCP Joins Alexza as Vice President, Medical Affairs
HSMN NewsFeed - 11 Sep 2007
Validus Pharmaceuticals Expands Product Portfolio with Acquisition of Bipolar Drug: Equetro(R)
Validus Pharmaceuticals Expands Product Portfolio with Acquisition of Bipolar Drug: Equetro(R)
HSMN NewsFeed - 10 Sep 2007
AtriCure Reports First Human Implant of the Cosgrove-Gillinov Left Atrial Appendage Occlusion System
AtriCure Reports First Human Implant of the Cosgrove-Gillinov Left Atrial Appendage Occlusion System
HSMN NewsFeed - 6 Aug 2007
Pfizer Says Growth in Phase II Portfolio Supports Goal of Tripling Phase III Portfolio by 2009
Pfizer Says Growth in Phase II Portfolio Supports Goal of Tripling Phase III Portfolio by 2009
HSMN NewsFeed - 1 Aug 2007
American Academy of Dermatology Says New Technologies Tighten Skin From Head to Toe Without Surgery
American Academy of Dermatology Says New Technologies Tighten Skin From Head to Toe Without Surgery
HSMN NewsFeed - 10 Jul 2007
Noven to Acquire JDS Pharmaceuticals, Expanding Business Model & Broadening Product Pipeline
Noven to Acquire JDS Pharmaceuticals, Expanding Business Model & Broadening Product Pipeline
HSMN NewsFeed - 9 Jul 2007
AtriCure's Isolator(R) Bipolar Ablation Clamp System Receives FDA 510(k) Clearance for Cardiac Use
AtriCure's Isolator(R) Bipolar Ablation Clamp System Receives FDA 510(k) Clearance for Cardiac Use
HSMN NewsFeed - 29 Jun 2007
Shire Announces Filing of VYVANSE(TM) (Lisdexamfetamine Dimesylate) for the Treatment of ADHD in Adults
Shire Announces Filing of VYVANSE(TM) (Lisdexamfetamine Dimesylate) for the Treatment of ADHD in Adults
HSMN NewsFeed - 28 Jun 2007
INVEGA(TM) Receives Marketing Authorization In European Union For Treatment Of Schizophrenia
INVEGA(TM) Receives Marketing Authorization In European Union For Treatment Of Schizophrenia
HSMN NewsFeed - 21 Jun 2007
LAB International licenses Fentanyl TAIFUN(R) to Janssen Pharmaceutica NV for Europe
LAB International licenses Fentanyl TAIFUN(R) to Janssen Pharmaceutica NV for Europe
HSMN NewsFeed - 15 May 2007
ArthroCare Receives FDA Clearance to Treat Malignant Lesions in the Spine
ArthroCare Receives FDA Clearance to Treat Malignant Lesions in the Spine
HSMN NewsFeed - 10 May 2007
Synergetics USA, Inc. Announces the Launch of the Largest Line of 23 Gauge Retinal Surgical Instruments
Synergetics USA, Inc. Announces the Launch of the Largest Line of 23 Gauge Retinal Surgical Instruments
HSMN NewsFeed - 4 May 2007
Bovie Medical Corporation Completes Acquisition of Remaining 50% Interest in J-Plasma
Bovie Medical Corporation Completes Acquisition of Remaining 50% Interest in J-Plasma
HSMN NewsFeed - 3 May 2007
Synergetics USA Announces First One Step(TM) Chandelier for Retina Surgery
Synergetics USA Announces First One Step(TM) Chandelier for Retina Surgery
HSMN NewsFeed - 3 May 2007
St. Jude Medical Announces U.S. And European Approvals of Zephyr Pacemaker Family of Devices
St. Jude Medical Announces U.S. And European Approvals of Zephyr Pacemaker Family of Devices
HSMN NewsFeed - 1 May 2007
New Data Shows Once a Day Lamictal(R) XR(TM) Is Effective in Treating Patients With Partial Seizures
New Data Shows Once a Day Lamictal(R) XR(TM) Is Effective in Treating Patients With Partial Seizures
HSMN NewsFeed - 27 Apr 2007
FDA Approves INVEGA (TM) for Long-Term Maintenance Treatment of Schizophrenia
FDA Approves INVEGA (TM) for Long-Term Maintenance Treatment of Schizophrenia
HSMN NewsFeed - 24 Apr 2007
Wright Medical Group, Inc. Expands Hip Product Portfolio With Key Product Launches
Wright Medical Group, Inc. Expands Hip Product Portfolio With Key Product Launches
HSMN NewsFeed - 13 Apr 2007
FDA Approves New Dose of RISPERDAL(R) CONSTA(R) for Schizophrenia Treatment
FDA Approves New Dose of RISPERDAL(R) CONSTA(R) for Schizophrenia Treatment
HSMN NewsFeed - 30 Mar 2007
Study Suggests INVEGA(TM) Helps Patients With Schizophrenia Maintain Symptom Control
Study Suggests INVEGA(TM) Helps Patients With Schizophrenia Maintain Symptom Control
HSMN NewsFeed - 20 Mar 2007
Barr Confirms Filing an Application with a Paragraph IV Certification for ABILIFY(R) Tablets
Barr Confirms Filing an Application with a Paragraph IV Certification for ABILIFY(R) Tablets
HSMN NewsFeed - 16 Mar 2007
Diffusion Pharmaceuticals Initiates Human Trial of Lead Drug Candidate, Trans Sodium Crocetinate (TSC)
Diffusion Pharmaceuticals Initiates Human Trial of Lead Drug Candidate, Trans Sodium Crocetinate (TSC)
HSMN NewsFeed - 4 Jan 2007
Eli Lilly and Company Statement Regarding Today's New York Times Article - January 4, 2007
Eli Lilly and Company Statement Regarding Today's New York Times Article - January 4, 2007
HSMN NewsFeed - 4 Jan 2007
Lilly and Plaintiffs' Attorneys Enter Into Agreements to Settle Zyprexa(R) Product Liability Litigation
Lilly and Plaintiffs' Attorneys Enter Into Agreements to Settle Zyprexa(R) Product Liability Litigation
HSMN NewsFeed - 3 Jan 2007
D-Pharm Announces Positive Phase IIb Trial Results for DP-b99 in Acute Stroke Patients
D-Pharm Announces Positive Phase IIb Trial Results for DP-b99 in Acute Stroke Patients
HSMN NewsFeed - 18 Dec 2006
Statement from Eli Lilly and Company: Response to The New York Times Article from December 18, 2006
Statement from Eli Lilly and Company: Response to The New York Times Article from December 18, 2006
HSMN NewsFeed - 1 Dec 2006
Lilly Responds to the Cost-Effectiveness Analysis of the CATIE Schizophrenia Trial
Lilly Responds to the Cost-Effectiveness Analysis of the CATIE Schizophrenia Trial
HSMN NewsFeed - 28 Nov 2006
Valleylab Announces New, Integrated ForceTriad(TM) Energy Platform for Electrosurgery
Valleylab Announces New, Integrated ForceTriad(TM) Energy Platform for Electrosurgery
HSMN NewsFeed - 16 Nov 2006
Shire Announces Results of its Bioequivalence Study of SPD465, an Investigational Drug for Adults with ADHD
Shire Announces Results of its Bioequivalence Study of SPD465, an Investigational Drug for Adults with ADHD
HSMN NewsFeed - 13 Nov 2006
Corcept Therapeutics Completes Enrollment in Third Phase 3 Study for Treating Psychotic Major Depression
Corcept Therapeutics Completes Enrollment in Third Phase 3 Study for Treating Psychotic Major Depression
HSMN NewsFeed - 2 Nov 2006
Synergetics Discloses Revenue Information Relating to Iridex Infringement Suit
Synergetics Discloses Revenue Information Relating to Iridex Infringement Suit
HSMN NewsFeed - 26 Oct 2006
DAYTRANA(TM) (methylphenidate transdermal system) Provides Individualized Symptom Management
DAYTRANA(TM) (methylphenidate transdermal system) Provides Individualized Symptom Management
HSMN NewsFeed - 12 Oct 2006
Laparoscopic Surgery Pioneer Invents New Device; Patton Surgical to Develop the Hasson H2(TM)
Laparoscopic Surgery Pioneer Invents New Device; Patton Surgical to Develop the Hasson H2(TM)
HSMN NewsFeed - 6 Oct 2006
FDA Approves RISPERDAL(R) for Treatment of Irritability Associated with Autistic Disorder
FDA Approves RISPERDAL(R) for Treatment of Irritability Associated with Autistic Disorder
HSMN NewsFeed - 29 Sep 2006
FDA Issues Approvable Letter for Paliperidone ER for the Treatment of Schizophrenia
FDA Issues Approvable Letter for Paliperidone ER for the Treatment of Schizophrenia
HSMN NewsFeed - 24 Jul 2006
AtriCure Announces Resignation of Chief Financial Officer - Thomas J. Etergino
AtriCure Announces Resignation of Chief Financial Officer - Thomas J. Etergino
HSMN NewsFeed - 18 Jul 2006
KARL STORZ Prepares for Launch of the New Bipolar Resectoscope and AUTOCON(R) II 400 ESU
KARL STORZ Prepares for Launch of the New Bipolar Resectoscope and AUTOCON(R) II 400 ESU
HSMN NewsFeed - 18 Jul 2006
AstraZeneca Submits NDA for Sustained Release Formulation of SEROQUEL(R) for Schizophrenia Treatment
AstraZeneca Submits NDA for Sustained Release Formulation of SEROQUEL(R) for Schizophrenia Treatment
HSMN NewsFeed - 29 Jun 2006
Noven Confirms Availability of Daytrana(TM) Methylphenidate Transdermal System
Noven Confirms Availability of Daytrana(TM) Methylphenidate Transdermal System
HSMN NewsFeed - 22 May 2006
New Studies Examine SEROQUEL(R) in Combination With Antidepressant Therapy in Patients With Depression
New Studies Examine SEROQUEL(R) in Combination With Antidepressant Therapy in Patients With Depression
HSMN NewsFeed - 22 May 2006
SureTek Medical Receives Four Clearances from FDA Office of Device Evaluation
SureTek Medical Receives Four Clearances from FDA Office of Device Evaluation
HSMN NewsFeed - 22 May 2006
Two Studies Indicate Coblation(R) Safely Treats Symptomatic Chondral Defects in the Knee
Two Studies Indicate Coblation(R) Safely Treats Symptomatic Chondral Defects in the Knee
Additional items found! 202

Members Archive contains
202 additional stories matching:
bipolar
(Password required)
bipolar
(Password required)